Trending...
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
TORONTO - Michimich -- STS Capital Partners is proud to announce the appointment of Steve Slovick as a Managing Director in Puerto Rico. Throughout his 36-year career, Steve has demonstrated his expertise in pricing, commercial launch strategy, business development, market access, and exit strategies within the life science sector.
He started out as Senior Vice President in the early 2000's for PriceSpective, a consulting firm that specialized in strategies to identify, capture, and communicate value for products, portfolios, and companies in the biopharmaceutical industry. PriceSpective was acquired by ICON Plc, where Steve was an important part of the acquisition process unlocking the synergies between the two companies maximizing financial value. His knowledge aligns with our mission at STS Capital, which is centered on helping our clients achieve Extraordinary Exits.
Steve's entrepreneurial spirit led him to establish Jupiter Life Science Consulting in 2015. As CEO and Managing Partner, he led a dedicated team in providing commercial and market access strategies for global pharmaceutical, biotech, and medical device companies. His commitment to addressing complex market access challenges positioned Jupiter as a leading authority in the industry. In 2022, Jupiter was acquired by Red Nucleus where he stayed on as Managing Partner and President MACS to provide guidance and long-term partnership to life science clients worldwide.
More on Michimich.com
Drawing from his firsthand experience of orchestrating successful exits, Steve offers a dual perspective as both a former business owner and a sell-side advisor. His comprehensive approach encompasses all aspects of the exit process, making him a valuable ally for business owners seeking a seamless transition.
Steve holds a Bachelor of Science in International Business and a Bachelor of Science in Marketing from the University of Colorado Boulder as well as a Master of Business Administration degree from Pepperdine Graziadio Business School.
"As a Managing Director at STS Capital Partners, Steve brings a wealth of experience and a track record of success to the table. With a career spanning decades, he has consistently demonstrated his ability to drive value and transformative initiatives within the pharmaceutical sector, aligning perfectly with our commitment to delivering maximum value and Extraordinary Exits for our clients." Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
More on Michimich.com
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital.
Visit www.stscapital.com.
He started out as Senior Vice President in the early 2000's for PriceSpective, a consulting firm that specialized in strategies to identify, capture, and communicate value for products, portfolios, and companies in the biopharmaceutical industry. PriceSpective was acquired by ICON Plc, where Steve was an important part of the acquisition process unlocking the synergies between the two companies maximizing financial value. His knowledge aligns with our mission at STS Capital, which is centered on helping our clients achieve Extraordinary Exits.
Steve's entrepreneurial spirit led him to establish Jupiter Life Science Consulting in 2015. As CEO and Managing Partner, he led a dedicated team in providing commercial and market access strategies for global pharmaceutical, biotech, and medical device companies. His commitment to addressing complex market access challenges positioned Jupiter as a leading authority in the industry. In 2022, Jupiter was acquired by Red Nucleus where he stayed on as Managing Partner and President MACS to provide guidance and long-term partnership to life science clients worldwide.
More on Michimich.com
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
Drawing from his firsthand experience of orchestrating successful exits, Steve offers a dual perspective as both a former business owner and a sell-side advisor. His comprehensive approach encompasses all aspects of the exit process, making him a valuable ally for business owners seeking a seamless transition.
Steve holds a Bachelor of Science in International Business and a Bachelor of Science in Marketing from the University of Colorado Boulder as well as a Master of Business Administration degree from Pepperdine Graziadio Business School.
"As a Managing Director at STS Capital Partners, Steve brings a wealth of experience and a track record of success to the table. With a career spanning decades, he has consistently demonstrated his ability to drive value and transformative initiatives within the pharmaceutical sector, aligning perfectly with our commitment to delivering maximum value and Extraordinary Exits for our clients." Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
More on Michimich.com
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital.
Visit www.stscapital.com.
Source: STS Capital Partners
0 Comments
Latest on Michimich.com
- Detroit Manufacturing Systems Completes Successful Aquisition Of Android Industries And Avancez Form
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- Roofman USA Encourages Ann Arbor Homeowners to Plan Ahead for Roof Replacements in 2026
- Wilderness Construction Highlights Design Details That Transform Bathrooms into Spa Sanctuaries
- Japanese Martial Arts Center Helps Students Find Strength and Balance Through Structured Training
- CMR Mechanical Shares Expert Tips to Prevent Furnace Breakdowns This Winter
- Detroit Puzzle Competition Concludes Final In-Person Round for $11,239 Prize
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Ohana Growth Partners Expands Into Wisconsin With Its First Planet Fitness Club
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
- BoxingRx Announces Full Gym Renovation Ahead of New Ownership's One-Year Anniversary
- UK Financial Ltd Announces It's Official Corporate Headquarters In The United Kingdom
- Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
- FreeTo.Chat - The bold, Anonymous Confession Platform, ushers in a new era of tension relief
- Female Founders Institute Announces Special Performance by Caitlin McGrath at the 2026 Charity Gala
